Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_430173a8ec6592d6fd4d799c44a42751 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2002-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c889f968aaef65b23c2f09ddeb3ec94c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_519b568120c950faf3180b9f7f187a5f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6132956488a00b42b77bbf927936c39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25412c2cc8cc758f2666c5c7b10c182a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3e6c03f397355d2b99dd3003fccfdd4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_167dc591c30d253ffe2c979b68ef9465 |
publicationDate |
2003-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
BG-107352-A |
titleOfInvention |
N- [4- (3-CHLORO-4-FLUOROPHENYLAMINO) -7- (3-MORPHOLIN-4-YLPROPYL) CHINAZOLIN-6-YL] -ACRYLAMIDE DIHYDROCHLORIDE |
abstract |
The invention relates to N- [4- (3-chloro-4-fluorophenylamino) -7- (3-morpholin-4-ylpropoxy) -quinazolin-6-yl] acrylamide dihydrochloride polymorphs. and to their use in the manufacture of medicaments having an irreversible inhibitory effect on tyrosine kinase. |
priorityDate |
2000-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |